Meanwhile, TMED5 plays a tumor-promoting role in the malignant development of cervical cancer by activating the Wnt7b/β-catenin signaling pathway, while Mir-183-5p can directly target TMED5 and inhibit its expression, so as to inhibit the occurrence of cervical cancer [33]. The gene discussed is TMED5; the disease is cervical carcinoma.